- Home
- AVIR vs HYI Comparison
AVIR vs HYI Comparison
Compare AVIR & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- HYI
- Stock Information
- Founded
- AVIR 2012
- HYI 2010
- Country
- AVIR United States
- HYI United States
- Employees
- AVIR N/A
- HYI N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- HYI Investment Managers
- Sector
- AVIR Health Care
- HYI Finance
- Exchange
- AVIR Nasdaq
- HYI Nasdaq
- Market Cap
- AVIR 273.0M
- HYI 270.2M
- IPO Year
- AVIR 2020
- HYI N/A
- Fundamental
- Price
- AVIR $3.67
- HYI $11.96
- Analyst Decision
- AVIR Hold
- HYI
- Analyst Count
- AVIR 1
- HYI 0
- Target Price
- AVIR $6.00
- HYI N/A
- AVG Volume (30 Days)
- AVIR 410.2K
- HYI 50.6K
- Earning Date
- AVIR 08-06-2025
- HYI 01-01-0001
- Dividend Yield
- AVIR N/A
- HYI 9.59%
- EPS Growth
- AVIR N/A
- HYI N/A
- EPS
- AVIR N/A
- HYI N/A
- Revenue
- AVIR N/A
- HYI N/A
- Revenue This Year
- AVIR N/A
- HYI N/A
- Revenue Next Year
- AVIR N/A
- HYI N/A
- P/E Ratio
- AVIR N/A
- HYI N/A
- Revenue Growth
- AVIR N/A
- HYI N/A
- 52 Week Low
- AVIR $2.46
- HYI $10.99
- 52 Week High
- AVIR $4.15
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- AVIR 76.11
- HYI 59.16
- Support Level
- AVIR $3.15
- HYI $11.82
- Resistance Level
- AVIR $3.35
- HYI $11.93
- Average True Range (ATR)
- AVIR 0.13
- HYI 0.06
- MACD
- AVIR 0.03
- HYI 0.00
- Stochastic Oscillator
- AVIR 83.81
- HYI 80.77
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.